Home > Gastroenterology > ECCO 2018 > IBD disease patterns and genetics > Quiescent disease, characteristics and biomarker correlations

Quiescent disease, characteristics and biomarker correlations

Conference
ECCO 2018
Trial
REACT, CALM

Quiescent disease in the first ten years after diagnosis

CD studies into long-term prognosis and disease course primarily describe steroid exposure, need for surgery or hospitalisations, and disease progression as characteristics of unfavourable outcomes. However, real-life data on long-term disease activity are lacking. Recent research aimed to define clusters of patients with different disease activity patterns in the population-based IBD South Limburg cohort [1].

In total, all CD patients from this cohort with at least ten years follow-up (age >18 years; diagnosed between 1991 and 2004) were included (n=432). The researchers found that during ten years follow-up after diagnosis, patients experienced 4.2 quarters of active disease on average. In contrast, 29.6% of patients were classified as quiescent, and among these 89.8% never received immunomodulators (IMM) or biologics. Ileocolonic disease location (odds ratio (OR) 0.45;...



Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on